NOD helps to drive quality improvement standards and is managed by The Royal College of Ophthalmologists. NOD supports our vision to ensure everyone has access to and receives high quality eye care for prevention and treatment of eye disease.
Using insights from the NOD, we are able to improve patient outcomes through systematic review of care against explicit criteria and implement changes in the delivery of services at a national and local level. By continuing to monitor the outcomes, we can continue to improve patient care and safety.
NOD informs aspects of care such as:
- risk factors of surgical treatment of cataracts, informing patient choice, shared decision making, consent information and training of surgeons
- informs regulatory bodies in the UK collaborating with the Care Quality Commission, Getting it Right First Time (ophthalmology) and the National Eye Care Restoration and Transformation Programme
- setting evidence based standards on what determines good care, where patients have received it
- highlighting health inequalities such as access to care and monitoring how this changes over time
- providing a national overview of the impact of interventions and empowering local comparison to drive change in services
The two areas of care currently analysed by the NOD are:
Funding
Roche Products Limited have provided funding to support the conduct of this study. Roche Products Limited has had no further involvement in the project. The project has been supported by an unrestricted, hands-off grant provided by Bayer plc. Bayer plc has no involvement whatsoever in the development or implementation of the project. We are grateful for the funding received from these organisations. We also receive ongoing support through subscription fees from participating hospitals.